30
Participants
Start Date
January 31, 2015
Primary Completion Date
February 28, 2015
Study Completion Date
March 31, 2015
Lasmiditan
2 discrete doses separated by 6 days.
Collaborators (1)
CoLucid Pharmaceuticals
INDUSTRY
Eli Lilly and Company
INDUSTRY